About Jitsubo

Vision

Enrich the world with smile

Mission

Everlasting contribution to human’s health worldwide
Creative contribution to society through invention and innovation

Officer

President & President
CEO
Kazuaki Kanai, Ph.D.

He joined Jitsubo in 2016 as Director of R&D and became CEO in December 2017. Prior to Jitsubo he was responsible for quality assurance of investigational drugs at  Daiichi Sankyo Co., Ltd (2007) and engaged in development of anti-cancer agents and antibacterial agents at  Daiichi Pharmaceutical Company after obtaining Ph.D. from Keio University in 1987.

He was a visiting scientist to Pfof. Rick L. Danheiser at MIT (1989-90)

Executive Vice President, CSO
Kiichiro Ohya

He joined Jitsubo in 2017 as a board member and became Executive Vice President in December 2019. Prior to Jitsubo, he held management positions in companies, Director, Universal Materials Incubator (2015), CTO, Inoac Corporation (2006), Chairman, Microhard Corporation(2004), President, JASDIC Park Co. (1997), President, KK Raychem  (1886) and VP, Celanese Japan (1983). He also worked as a management consultant at McKinsey Inc, (1977) and project manager at JGC Corporation after he obtained chemical engineering degree from Waseda University (1964)

Board Director
Kazunobu Nishimura
Managing Director,
SHINSEI CORPORATE INVESTMENT LIMITED
Board Director
Masato Miyauchi
Vice President, Accounting Dept.
Sosei Group Corporation
Audit & Supervisory Board Member
Tsuyoshi Dai
TSUYOSHI DAI & PARTNERS

Company

Company Name Jitsubo CO., LTD.
Address Life Science Research Center 4-1 1-1-43 Suehiro-cho, Tsurumi, Yokohama, Kanagawa-pref. 230-0045 Japan
Founded April 8, 2005
Equity Capital 302,250,000 JPY
Total Employee 20
Business Development of peptide manufacturing process, Molecular Hiving ™
Contract manufacturing of APIs and Licensing
appearance
PAGE TOP